- Home
- MAIA vs AIXI Comparison
MAIA vs AIXI Comparison
Compare MAIA & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- AIXI
- Stock Information
- Founded
- MAIA 2018
- AIXI 2001
- Country
- MAIA United States
- AIXI China
- Employees
- MAIA N/A
- AIXI N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- MAIA Health Care
- AIXI Technology
- Exchange
- MAIA Nasdaq
- AIXI Nasdaq
- Market Cap
- MAIA 44.8M
- AIXI 43.9M
- IPO Year
- MAIA 2022
- AIXI 2023
- Fundamental
- Price
- MAIA $1.48
- AIXI $4.01
- Analyst Decision
- MAIA
- AIXI
- Analyst Count
- MAIA 0
- AIXI 0
- Target Price
- MAIA N/A
- AIXI N/A
- AVG Volume (30 Days)
- MAIA 124.0K
- AIXI 62.6K
- Earning Date
- MAIA 05-13-2025
- AIXI 04-29-2025
- Dividend Yield
- MAIA N/A
- AIXI N/A
- EPS Growth
- MAIA N/A
- AIXI N/A
- EPS
- MAIA N/A
- AIXI N/A
- Revenue
- MAIA N/A
- AIXI $65,643,604.00
- Revenue This Year
- MAIA N/A
- AIXI $22.85
- Revenue Next Year
- MAIA N/A
- AIXI $22.70
- P/E Ratio
- MAIA N/A
- AIXI N/A
- Revenue Growth
- MAIA N/A
- AIXI 6.22
- 52 Week Low
- MAIA $1.46
- AIXI $2.06
- 52 Week High
- MAIA $5.99
- AIXI $16.65
- Technical
- Relative Strength Index (RSI)
- MAIA 35.67
- AIXI 45.98
- Support Level
- MAIA $1.52
- AIXI $3.82
- Resistance Level
- MAIA $1.95
- AIXI $4.45
- Average True Range (ATR)
- MAIA 0.11
- AIXI 0.42
- MACD
- MAIA -0.01
- AIXI 0.05
- Stochastic Oscillator
- MAIA 5.09
- AIXI 59.63
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.